$ cat ./records/gates-foundation-commits-50-million-to-china-hiv-aids-prevention-2007.txt
Gates Foundation Commits $50 Million to China HIV/AIDS Prevention
[RECORD.TXT] · cat --full
The Bill & Melinda Gates Foundation committed $50 million to HIV/AIDS prevention in China, targeting high-risk populations including injection drug users, sex workers, and migrant workers. The program partnered with the Chinese government and domestic NGOs to expand harm reduction services, voluntary testing, and treatment access in provinces with high HIV prevalence. It was among the foundation's earliest and largest China health commitments.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Funds Africa Harvest Sorghum Biofortification Project — Iron-Rich Varieties for East African Smallholders
Next →
Receives Honorary Doctorate from Tsinghua University
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.